Publications

Publications

Classement par date

  • Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination
    Rodrigo Nalio Ramos, et al. Clinical & Translational Immunology, May 8 2022 – Read the article Publication
  • Phase I trials of personalized cancer vaccine TG4050 in surgically treated high-risk head and neck squamous cell carcinoma (HNSCC) and relapsing ovarian cancer (OvC) patients

    MS Block et al.
    AACR 2022
    Read the abstract here – Download the poster here
    Poster Presentation

  • Comprehensive preclinical studies of BT-001: an oncolytic vaccinia virus armed with Treg-depleting @CTLA4 and GM-CSF

    JB Marchand et al.
    AACR 2022
    Read the abstract here – Download the poster here
    Poster Presentation

  • Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors

    Semmrich M, Marchand J, Fend L, et al
    Journal for ImmunoTherapy of Cancer 2022;10:e003488.
    doi: 10.1136/jitc-2021-003488
    Download the publication here

Classement par produit